Immunovant, Inc. Quarterly Current Income Tax Expense (Benefit) in USD for Q3 2019
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Immunovant, Inc. annual/quarterly Current Income Tax Expense (Benefit) history and growth rate for Q3 2019.
- Immunovant, Inc. Current Income Tax Expense (Benefit) for the quarter ending September 30, 2019 was $138K.
- Immunovant, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $567K, a 6200% increase from 2022.
- Immunovant, Inc. annual Current Income Tax Expense (Benefit) for 2022 was $9K.
- Immunovant, Inc. annual Current Income Tax Expense (Benefit) for 2021 was -$84K, a 76.5% increase from 2020.
Current Income Tax Expense (Benefit), Quarterly (USD)